Adicet Bio, Inc. (ACET) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Adicet Bio, Inc. on April 28, 2026, covering events occurring on April 27, 2026. The company is incorporated in Delaware and its common stock trades on The Nasdaq Capital Market under the symbol "ACET".
Key Financial Metrics
The filing does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on a specific securities transaction.
Material Changes and Transaction Details
On April 27, 2026, the Company entered into an exchange agreement with RA Capital Management, L.P. and RA Capital Healthcare Fund, L.P. (collectively, RA Capital). The key terms of the transaction are:
- Exchange: RA Capital exchanged 250,000 shares of Adicet Bio common stock for a pre-funded warrant.
- Warrant Terms: The pre-funded warrant allows for the acquisition of 250,000 shares of common stock at an exercise price of $0.0001 per share.
- Exercise Method: The warrant is exercisable immediately via cashless exercise.
- Ownership Limitations: Exercise is restricted if it would cause the holder's beneficial ownership to exceed 9.99% of outstanding shares or voting power. This limit may be increased to 19.99% with at least 61 days' prior notice.
- Regulatory Basis: The issuance was made without registration under Section 3(a)(9) of the Securities Act of 1933.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the standard terms of the pre-funded warrant agreement.
Investor Verification Checklist
- Verify the current share count to assess the impact of the 250,000 share exchange on total outstanding shares.
- Confirm RA Capital's current beneficial ownership percentage to determine if the 9.99% limitation applies to future exercises.
- Review the full text of the Pre-Funded Warrant (Exhibit 4.1) for specific adjustment provisions regarding stock splits or dividends.
- Check subsequent filings for any cashless exercises of the warrant.